Warfarin Sodium
- Product NDC
- 43353-029
- 11-digit product format
- 433530029
- Labeler code
- 43353
- Product ID
- 43353-029_49001c15-cda7-00e5-e063-6394a90a0853
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Warfarin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA090935
- Marketing category
- ANDA
- Marketing start
- 2015-04-08
- Substance
- WARFARIN SODIUM
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090935-001 | WARFARIN SODIUM | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-002 | WARFARIN SODIUM | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-003 | WARFARIN SODIUM | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-004 | WARFARIN SODIUM | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-005 | WARFARIN SODIUM | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-006 | WARFARIN SODIUM | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-007 | WARFARIN SODIUM | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-008 | WARFARIN SODIUM | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2011-05-25 | |
| A090935-009 | WARFARIN SODIUM | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2011-05-25 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090935-001 | AB |
| A090935-002 | AB |
| A090935-003 | AB |
| A090935-004 | AB |
| A090935-005 | AB |
| A090935-006 | AB |
| A090935-007 | AB |
| A090935-008 | AB |
| A090935-009 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A090935-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A090935-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2011-05-25 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2011-05-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2011-05-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2011-05-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2011-05-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2011-05-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2011-05-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2011-05-25 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A090935-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-006 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-007 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-008 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A090935-009 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-006 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-007 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-008 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090935-009 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-006 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-007 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-008 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090935-009 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-005 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-006 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-007 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-008 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090935-009 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090935-004 | AB | 1 | fd3edfee7708… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Warfarin Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| WARFARIN SODIUM | 2.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6153CWM0CL | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4f276251-49b7-438f-9c47-f1cdfc47e519 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| abcfe2f4-1eca-fdc3-341b-b8134a1aec1f | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43353-029-30 | Warfarin Sodium | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 43353-029-35 | Warfarin Sodium | 35 in 1 BOTTLE | TABLET | 35 | 3 | |
| 43353-029-40 | Warfarin Sodium | 40 in 1 BOTTLE | TABLET | 40 | 3 | |
| 43353-029-45 | Warfarin Sodium | 45 in 1 BOTTLE | TABLET | 45 | 3 | |
| 43353-029-53 | Warfarin Sodium | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 43353-029-60 | Warfarin Sodium | 90 in 1 BOTTLE | TABLET | 90 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43353-029-30 | EA - Each | 43353-029 | 710bbe68-996e-4ca1-9b44-7e0aa25cdb2a | 1 | 2016-07-19 |
| 43353-029-35 | EA - Each | 43353-029 | cf8a85d7-342e-4e2b-b806-a9b257f80b24 | 1 | 2016-07-19 |
| 43353-029-40 | EA - Each | 43353-029 | 9766e471-6f39-4fd3-90df-1059be678433 | 1 | 2016-07-19 |
| 43353-029-45 | EA - Each | 43353-029 | ae2ebad1-f403-43c6-ae97-41af5eeae445 | 1 | 2016-07-19 |
| 43353-029-53 | EA - Each | 43353-029 | f335e55e-c46e-44f8-a9a8-6d3b3c6d0a0e | 1 | 2016-07-19 |
| 43353-029-60 | EA - Each | 43353-029 | 66eb1a7d-c3a9-4a43-af06-2517ba29c440 | 1 | 2016-07-19 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Warfarin Sodium | WARFARIN | Aphena Pharma Solutions - Tennessee, LLC | 4f276251-49b7-438f-9c47-f1cdfc47e519 | 2026-01-22 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 43353-029 |
| Warfarin Sodium | WARFARIN | Golden State Medical Supply, Inc. | a2f6c9f7-87dc-7428-e053-2995a90a1de6 | 2025-07-17 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
| WARFARIN SODIUM | WARFARIN SODIUM | DIRECT RX | c186d1ff-64dd-bfcb-e053-2a95a90af800 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
| Warfarin Sodium | WARFARIN | Aphena Pharma Solutions - Tennessee, LLC | 52b3c2f6-b5ca-44ae-bdcc-552d5191034f | 2021-01-28 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
| Warfarin Sodium | WARFARIN | Aphena Pharma Solutions - Tennessee, LLC | a98916a5-cdb2-4251-bdea-0245c763b2f1 | 2020-12-15 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
| Warfarin Sodium | WARFARIN | Exelan Pharmaceuticals Inc. | c0cc4511-e656-4b6d-96cd-e02e76173b9d | 2020-09-09 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
| Warfarin Sodium | WARFARIN | Aphena Pharma Solutions - Tennessee, LLC | 91f24482-d4cb-4a09-a97e-64f6e49071ee | 2020-08-03 | Boxed warning, Warnings, Adverse reactions | 090935 ANDA090935 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 43353-029-30 | 43353002930 | 30 TABLET in 1 BOTTLE (43353-029-30) | 30 tablet | 2015-05-04 | 0000-00-00 | No | No | Current |
| 43353-029-35 | 43353002935 | 35 TABLET in 1 BOTTLE (43353-029-35) | 35 tablet | 2015-05-24 | 0000-00-00 | No | No | Current |
| 43353-029-40 | 43353002940 | 40 TABLET in 1 BOTTLE (43353-029-40) | 40 tablet | 2015-05-04 | 0000-00-00 | No | No | Current |
| 43353-029-45 | 43353002945 | 45 TABLET in 1 BOTTLE (43353-029-45) | 45 tablet | 2015-05-04 | 0000-00-00 | No | No | Current |
| 43353-029-53 | 43353002953 | 60 TABLET in 1 BOTTLE (43353-029-53) | 60 tablet | 2015-05-17 | 0000-00-00 | No | No | Current |
| 43353-029-60 | 43353002960 | 90 TABLET in 1 BOTTLE (43353-029-60) | 90 tablet | 2015-05-04 | 0000-00-00 | No | No | Current |